Heterozygous mutations in PALB2 cause DNA replication and damage response defects.

Area of Science:

• Genetics
• Molecular Biology
• Oncology

Background:

• Heterozygous defects in PALB2, alongside BRCA1/BRCA2 mutations, are significant in hereditary breast cancer.
• PALB2 heterozygosity elevates malignancy risk approximately sixfold.
• PALB2 functions with BRCA1/BRCA2 in homologous recombination and DNA damage response.

Purpose of the Study:

• To investigate the cellular and organismal consequences of PALB2 haploinsufficiency in breast cancer predisposition.
• To elucidate the specific mechanisms of DNA replication and damage response defects in PALB2 mutation carriers.

Main Methods:

• Analysis of lymphoblastoid cell lines from heterozygous female PALB2 mutation carriers.
• Assessment of DNA replication dynamics, including origin firing and replication fork progression.
• Evaluation of DNA damage response pathways, including ATR, Chk1, and Chk2 signaling.
• Examination of chromosome instability in primary blood lymphocytes.

Main Results:

• PALB2 haploinsufficiency leads to aberrant DNA replication, characterized by increased origin firing and reduced replication fork spacing.
• Elevated ATR protein levels were observed, though not phosphorylation levels.
• A majority of carrier cell lines exhibited aberrant Chk1/Chk2-mediated DNA damage response.
• Increased chromosome instability was detected in lymphocytes of PALB2 mutation carriers.

Conclusions:

• PALB2 haploinsufficiency disrupts DNA replication and damage response, contributing to genome destabilization.
• These findings reveal a novel mechanism in early breast cancer development.
• The study suggests these mechanisms may be relevant for other heterozygous mutations in homologous recombination pathway genes involved in hereditary cancer.